| 产品详情 |
| Edit |   |
|---|
| Product Name | Canertinib, Dihydrochloride |
|---|
| Description | Purity ~99% HPLC, TLC. Canertinib (CI-1033, PD 183805) is a pan-erbB tyrosine kinase inhibitor. It selectively inhibits erbB1 (epidermal growth factor receptor), erbB2, erbB3, and erbB4 without blocking tyrosine kinase activity of many other receptors such as platelet-derived growth factor receptor, fibroblast growth factor receptor, and insulin receptor. Solubility: Soluble in DMSO at 100mg/ml; soluble in ethanol at 1mg/ml with warming; soluble in water at 10mg/ml with warming; buffers, serum, or other additives may increase or decrease the aqueous solubility. Compound is somewhat unstable in HPLC sample solution at room temperature. |
|---|
| Size | 25mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Canertinib, Dihydrochloride (N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide Dihydrochloride, CI-1033, PD183805) |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | C1075-25 |
|---|
| Price | |
|---|
| Order / More Info | Canertinib, Dihydrochloride from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|